Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients

Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients

(2011) A. D. Shapiro et al.   BLOOD

Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1

(2010) Stefan Zeuzem et al.   GASTROENTEROLOGY

Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia

(2010) P. W. COLLINS et al.   HAEMOPHILIA

Diagnosis and quantification of factor VIII inhibitors

(2009) B. VERBRUGGEN   HAEMOPHILIA

Half-life extension through albumin fusion technologies

(2009) Stefan Schulte   THROMBOSIS RESEARCH

A survey of adherence to haemophilia therapy in six European countries: results and recommendations

(2008) P. DE MOERLOOSE et al.   HAEMOPHILIA